S&P 500   4,290.89 (-1.07%)
DOW   33,715.62 (-0.86%)
QQQ   355.24 (-1.22%)
AAPL   172.54 (-2.01%)
MSFT   312.27 (-1.66%)
META   299.00 (-0.61%)
GOOGL   127.90 (-2.45%)
AMZN   127.44 (-2.92%)
TSLA   246.81 (-0.07%)
NVDA   421.20 (-0.24%)
NIO   8.49 (+1.68%)
BABA   86.08 (-1.31%)
AMD   96.20 (-1.21%)
T   15.06 (+0.00%)
F   12.51 (-0.56%)
MU   68.20 (-0.55%)
CGC   0.95 (+0.39%)
GE   109.99 (-1.55%)
DIS   80.52 (-0.60%)
AMC   8.17 (+0.37%)
PFE   32.87 (-0.33%)
PYPL   59.05 (+0.32%)
NFLX   382.43 (-0.62%)
S&P 500   4,290.89 (-1.07%)
DOW   33,715.62 (-0.86%)
QQQ   355.24 (-1.22%)
AAPL   172.54 (-2.01%)
MSFT   312.27 (-1.66%)
META   299.00 (-0.61%)
GOOGL   127.90 (-2.45%)
AMZN   127.44 (-2.92%)
TSLA   246.81 (-0.07%)
NVDA   421.20 (-0.24%)
NIO   8.49 (+1.68%)
BABA   86.08 (-1.31%)
AMD   96.20 (-1.21%)
T   15.06 (+0.00%)
F   12.51 (-0.56%)
MU   68.20 (-0.55%)
CGC   0.95 (+0.39%)
GE   109.99 (-1.55%)
DIS   80.52 (-0.60%)
AMC   8.17 (+0.37%)
PFE   32.87 (-0.33%)
PYPL   59.05 (+0.32%)
NFLX   382.43 (-0.62%)
S&P 500   4,290.89 (-1.07%)
DOW   33,715.62 (-0.86%)
QQQ   355.24 (-1.22%)
AAPL   172.54 (-2.01%)
MSFT   312.27 (-1.66%)
META   299.00 (-0.61%)
GOOGL   127.90 (-2.45%)
AMZN   127.44 (-2.92%)
TSLA   246.81 (-0.07%)
NVDA   421.20 (-0.24%)
NIO   8.49 (+1.68%)
BABA   86.08 (-1.31%)
AMD   96.20 (-1.21%)
T   15.06 (+0.00%)
F   12.51 (-0.56%)
MU   68.20 (-0.55%)
CGC   0.95 (+0.39%)
GE   109.99 (-1.55%)
DIS   80.52 (-0.60%)
AMC   8.17 (+0.37%)
PFE   32.87 (-0.33%)
PYPL   59.05 (+0.32%)
NFLX   382.43 (-0.62%)
S&P 500   4,290.89 (-1.07%)
DOW   33,715.62 (-0.86%)
QQQ   355.24 (-1.22%)
AAPL   172.54 (-2.01%)
MSFT   312.27 (-1.66%)
META   299.00 (-0.61%)
GOOGL   127.90 (-2.45%)
AMZN   127.44 (-2.92%)
TSLA   246.81 (-0.07%)
NVDA   421.20 (-0.24%)
NIO   8.49 (+1.68%)
BABA   86.08 (-1.31%)
AMD   96.20 (-1.21%)
T   15.06 (+0.00%)
F   12.51 (-0.56%)
MU   68.20 (-0.55%)
CGC   0.95 (+0.39%)
GE   109.99 (-1.55%)
DIS   80.52 (-0.60%)
AMC   8.17 (+0.37%)
PFE   32.87 (-0.33%)
PYPL   59.05 (+0.32%)
NFLX   382.43 (-0.62%)
NASDAQ:INCR

InterCure (INCR) Stock Forecast, Price & News

$1.57
-0.03 (-1.88%)
(As of 11:50 AM ET)
Compare
Today's Range
$1.55
$1.57
50-Day Range
$1.39
$1.72
52-Week Range
$1.39
$5.56
Volume
13,509 shs
Average Volume
51,827 shs
Market Capitalization
N/A
P/E Ratio
12.08
Dividend Yield
N/A
Price Target
$5.00

InterCure MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
212.5% Upside
$5.00 Price Target
Short Interest
Healthy
0.13% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.30 out of 5 stars


INCR stock logo

About InterCure (NASDAQ:INCR) Stock

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

INCR Price History

INCR Stock News Headlines

Closing Bell: Intercure Ltd up on Monday (INCR-U)
Unlock the treasure on Mount Olympus with this little-known mining stock.
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
U.S. drive to onshore battery supply chains could create big winners in lithium
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
Closing Bell: Intercure Ltd down on Monday (INCR-U)
Closing Bell: Intercure Ltd flat on Monday (INCR-U)
Closing Bell: Intercure Ltd flat on Friday (INCR-U)
Closing Bell: Intercure Ltd down on Friday (INCR-U)
Closing Bell: Intercure Ltd flat on Wednesday (INCR-U)
Closing Bell: Intercure Ltd down on Wednesday (INCR-U)
Closing Bell: Intercure Ltd up on Thursday (INCR-U)
Intercure Ltd
See More Headlines
Receive INCR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InterCure and its competitors with MarketBeat's FREE daily newsletter.

INCR Company Calendar

Last Earnings
8/31/2023
Today
9/26/2023
Next Earnings (Estimated)
11/21/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:INCR
Fax
N/A
Employees
370
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$5.00
High Stock Price Forecast
$5.00
Low Stock Price Forecast
$5.00
Forecasted Upside/Downside
+212.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$13.36 million
Pretax Margin
6.32%

Debt

Sales & Book Value

Annual Sales
$115.83 million
Cash Flow
$0.39 per share
Book Value
$3.64 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.03
10 Best Stocks to Own in 2023 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2023 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Alexander Rabinovitch (Age 52)
    CEO & Director
  • Mr. Amos Cohen (Age 44)
    Chief Financial Officer
  • Einat Zehavi
    VP of Sales
  • Mr. Rami Levy (Age 58)
    Chief Operating Officer of Canndoc
  • Mr. Omri Batzir
    Corp. Controller













INCR Stock - Frequently Asked Questions

Should I buy or sell InterCure stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for InterCure in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" INCR shares.
View INCR analyst ratings
or view top-rated stocks.

What is InterCure's stock price forecast for 2023?

1 brokerages have issued 12 month target prices for InterCure's stock. Their INCR share price forecasts range from $5.00 to $5.00. On average, they expect the company's share price to reach $5.00 in the next year. This suggests a possible upside of 212.5% from the stock's current price.
View analysts price targets for INCR
or view top-rated stocks among Wall Street analysts.

How have INCR shares performed in 2023?

InterCure's stock was trading at $3.30 on January 1st, 2023. Since then, INCR stock has decreased by 51.5% and is now trading at $1.60.
View the best growth stocks for 2023 here
.

Are investors shorting InterCure?

InterCure saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 34,900 shares, an increase of 156.6% from the August 15th total of 13,600 shares. Based on an average daily trading volume, of 46,500 shares, the short-interest ratio is presently 0.8 days. Approximately 0.1% of the shares of the company are short sold.
View InterCure's Short Interest
.

When is InterCure's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 21st 2023.
View our INCR earnings forecast
.

How were InterCure's earnings last quarter?

InterCure Ltd. (NASDAQ:INCR) issued its quarterly earnings data on Thursday, August, 31st. The company reported $0.03 earnings per share for the quarter. The firm had revenue of $28.08 million for the quarter. InterCure had a net margin of 4.28% and a trailing twelve-month return on equity of 3.37%.

What is InterCure's stock symbol?

InterCure trades on the NASDAQ under the ticker symbol "INCR."

Who are InterCure's major shareholders?

InterCure's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Mirae Asset Global Investments Co. Ltd. (1.20%), Cambria Investment Management L.P. (0.14%) and Citadel Advisors LLC (0.00%).

How do I buy shares of InterCure?

Shares of INCR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is InterCure's stock price today?

One share of INCR stock can currently be purchased for approximately $1.60.

How many employees does InterCure have?

The company employs 370 workers across the globe.

How can I contact InterCure?

The official website for the company is www.intercure.co. The company can be reached via phone at 972774605012.

This page (NASDAQ:INCR) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -